IL1RL1 rs212388: Understanding Your Genetic Variant
The rs212388 variant is a single-nucleotide polymorphism located within the IL1RL1 gene, which encodes the ST2 receptor. This variant is associated with the regulation of soluble ST2 (sST2) levels and the interleukin-33 (IL-33) signaling pathway, both of which play roles in immune responses and inflammatory conditions like asthma.
What each genotype means
Typical IL1RL1 expression profile
This genotype represents the more common variant at this position in many populations. Research suggests that variations in the IL1RL1 gene can influence the expression of the sST2 protein, which acts as a decoy receptor for IL-33 and may modulate type 2 inflammatory responses. This variant is studied for its potential role in asthma susceptibility, though individual risk is influenced by many genetic and environmental factors.
This genotype is common in many global populations, though frequencies vary significantly by ancestry.
Intermediate IL1RL1 expression profile
Carrying one copy of each allele may result in intermediate levels of sST2 protein expression compared to homozygous individuals. Because this variant is located in an intronic regulatory region, it is thought to influence how the IL1RL1 gene is regulated in airway tissues. You should discuss any concerns regarding respiratory health or asthma management with your healthcare provider.
This heterozygous genotype is frequently observed in populations of European and East Asian ancestry.
Altered IL1RL1 expression profile
This genotype is associated with differences in the regulation of the IL1RL1 gene, which encodes the ST2 receptor. Studies indicate that such variants can influence the production of soluble ST2 (sST2), potentially affecting how the body responds to IL-33 signaling in the airways. This is a subject of ongoing research regarding its association with asthma and allergic sensitization, but it is not a diagnostic marker.
This genotype is carried by a significant portion of the population, with higher frequencies observed in East Asian cohorts compared to European populations.
What is the rs212388 Variant?
The rs212388 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), situated in the intronic region of the IL1RL1 gene. Introns are non-coding segments of DNA that reside within a gene but are removed during the process of creating a protein. Despite being non-coding, intronic variants like rs212388 can act as regulatory elements, influencing how much of a protein is produced or how a gene is expressed in different tissues. In the case of rs212388, research suggests it may influence the expression of sST2, a soluble form of the ST2 receptor. By sitting in a regulatory region, this SNP may alter the fine-tuning of immune signaling pathways, making it a subject of interest for researchers investigating the genetic architecture of inflammatory traits.
The Role of the IL1RL1 Gene
The IL1RL1 gene provides instructions for making the ST2 protein, which is a member of the interleukin-1 receptor family. This protein exists in two primary forms: a membrane-bound receptor (ST2L) and a soluble form (sST2). The membrane-bound receptor acts as a signaling molecule for interleukin-33 (IL-33), a cytokine that promotes type 2 inflammation, which is a key component of allergic responses and asthma. Conversely, the soluble form, sST2, acts as a 'decoy' receptor. It binds to IL-33 in the bloodstream or tissues, preventing it from interacting with the membrane-bound receptor. By sequestering IL-33, sST2 effectively dampens or regulates the inflammatory signal. Because of this balancing act, variations in the IL1RL1 gene can potentially shift the equilibrium between promoting and inhibiting inflammation.
Research and Evidence Strength
Current research into rs212388 and other variants in the IL1RL1 locus is primarily focused on their association with asthma susceptibility and inflammatory markers. Genome-wide association studies (GWAS) have consistently identified the IL1RL1 region as a hotspot for asthma-related genetic signals. However, the evidence linking rs212388 specifically to clinical outcomes remains limited. While some studies suggest that variants in this gene influence sST2 levels and the severity of asthma exacerbations, the functional impact of this specific SNP is still being characterized. It is important to note that genetic associations do not imply direct causation. Many factors, including environmental triggers, lifestyle, and the interplay of hundreds of other genetic variants, contribute to complex conditions like asthma. Therefore, the clinical utility of this variant for individual health prediction is currently considered low.
What You Can Do With This Information
Understanding your genetic variants can be an educational journey, but it is vital to maintain a clear perspective on what this information means for your health. Genetic data regarding variants like rs212388 is intended for research and informational purposes only. It is not a diagnostic tool and cannot predict whether you will develop a specific condition or how you will respond to a particular medication. If you have concerns about asthma, allergies, or your immune health, the most effective approach is to consult with a qualified healthcare provider or an allergist. They can evaluate your symptoms, medical history, and clinical test results to provide personalized care. Never make changes to your medications or treatment plans based on genetic reports without first discussing them with your clinician or pharmacist.
How common is this variant?
The minor allele frequency for rs212388 is approximately 0.35 in European populations and approximately 0.45 in East Asian populations.
Frequently asked questions
Is rs212388 a diagnostic test for asthma?
No, rs212388 is not a diagnostic test. Asthma is a complex condition influenced by many genetic and environmental factors, and this SNP is only one of many markers studied in research settings.
Can I use this SNP to choose my asthma medication?
No. Genetic variants like rs212388 should not be used to guide medication choices. Always discuss your treatment plan and any concerns about medication efficacy with your doctor or pharmacist.
What does it mean if I have the minor allele?
Having the minor allele simply means you carry a specific genetic variation that is common in the population. It does not necessarily mean you have an increased risk of disease or any specific health trait.
Where can I find more information on IL1RL1?
You can explore resources like the NCBI Gene database or MedlinePlus Genetics for comprehensive, peer-reviewed information on the function and clinical associations of the IL1RL1 gene.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs212388?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL1RL1
An intergenic regulatory variant upstream of IL1RL1 that influences circulating soluble ST2 levels and severity of allergic rhinitis.
This variant in the IL1RL1/IL18R1 locus influences ST2 receptor expression and modifies individual susceptibility to allergic sensitization and asthma.
Intronic regulatory variant in the IL1RL1/IL18R1 cluster modulating ST2 receptor expression and inflammatory disease risk.
ST2/interleukin-1 receptor-like 1 variant associated with altered IL-33 signaling and heightened risk for allergic asthma and atopy.
A regulatory variant within the IL1RL1 (ST2) gene locus associated with allergic rhinitis, eosinophil count regulation, and atopic asthma susceptibility.
Variant in IL1RL1 (ST2) associated with allergic inflammation and cytokine production.